Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,755,720
+$99,365,404 QoQ
Shares Held
281,000
+3182.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#144
of 3,131 holders
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$101,393,600
PutShares
280,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. AMGN ranks #2 (25.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
This page
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in AMGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,393,600 | 280,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $101,755,720 | 281,000 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $26,134,056 | 93,600 | Put | Sole | 2025-08-18 | |
| 2025-06-30 | $2,121,996 | 7,600 | Call | Sole | 2025-08-18 | |
| 2025-06-30 | $2,390,316 | 8,561 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $10,445,025 | 33,526 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $163,501,440 | 524,800 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $53,960,460 | 173,200 | Call | Sole | 2025-05-14 | |
| 2024-06-30 | $3,124,500 | 10,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,526,208 | 114,400 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,281,200 | 60,000 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $38,409,460 | 173,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,208,750 | 5,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $54,602,856 | 207,900 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $2,296,620 | 10,800 | Shares | Sole | 2021-12-29 | |
| No filing history on record for this holder in this stock. | ||||||